New Mexico Honey Wound Treatment Research Study
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Size of lesion at day 7
研究概览
简要总结
In a time of emerging bacteria that are resistant to antibiotics, honey offers an alternative that has potential to reduce the heavy reliance on pharmaceutical antibiotics. We will be evaluating the effectiveness of a locally produced New Mexico Honey against the standard of care Bactrim antibiotic on Community Acquired MRSA.
详细描述
Locally grown New Mexico Honey will be utilized on abscess wounds of the trunk and extremities vs routine (Bactrim) antibiotic care to determine if NM Honey is effective treatment for Community Acquired MRSA 6 cm abscesses.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 16 Years 至 75 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Patients 16 years of age or older
- •Abscess less than or equal to 6 cm in diameter on the extremity or trunk requiring incision and drainage
- •Patient willing to try honey prepared dressing
- •Patient able to return to office each day for 7 days for evaluation
排除标准
- •Under the age of 16
- •Abscess of face, scalp or genitals
- •Diagnosed as a diabetic
- •Allergic to bee pollen, honey or sulfa antibiotics
- •Diagnosed with peripheral vascular disease
- •Patient acknowledgement of current drug or alcohol abuse
研究组 & 干预措施
NM Regional Honey
15 ml of NM Honey applied directly to wound
干预措施: New Mexico Honey (Drug)
NM Regional Honey
15 ml of NM Honey applied directly to wound
干预措施: Bactrim DS (Drug)
Bactrim DS
Standard of Care Oral Antibiotic
干预措施: New Mexico Honey (Drug)
Bactrim DS
Standard of Care Oral Antibiotic
干预措施: Bactrim DS (Drug)
结局指标
主要结局
Size of lesion at day 7
时间窗: 7 days
Increase in size will determine failure; Decrease in size will determine success
次要结局
未报告次要终点
研究者
R. Stephen Rankin, M.D.
Primary Investigator
Rankin, R. Stephen, M.D.